Girisopam

Girisopam
Systematic (IUPAC) name
1-(3-chlorophenyl)- 7,8-dimethoxy- 4-methyl- 5H-2,3-benzodiazepine
Clinical data
Identifiers
82230-53-3 Yes
None
PubChem CID 71257
ChemSpider 64387 Yes
UNII 2LP301A921 Yes
ChEMBL CHEMBL1915065 
Chemical data
Formula C18H17ClN2O2
328.79
  (what is this?)  (verify)

Girisopam[1] (GYKI-51189) is a drug which is a 2,3-benzodiazepine derivative, related to tofisopam.[2] It has selective anxiolytic action with no sedative, anticonvulsant or muscle relaxant effects.[3][4][5]

See also

References

  1. ↑ US Patent 4322346
  2. ↑ Psychotropics.dk
  3. ↑ Andrási F, Horváth K, Sineger E, Berzsenyi P, Borsy J, Kenessey A, Tarr M, Láng T, Kórösi J, Hámori T. Neuropharmacology of a new psychotropic 2,3-benzodiazepine. Arzneimittelforschung. 1987 Oct;37(10):1119-24.
  4. ↑ Horváth K, Andrási F, Botka P, Hámori T. Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone. Acta Physiologica Hungarica. 1992;79(2):153-61.
  5. ↑ Horváth EJ, Salamon C, Bakonyi A, Fekete MI, Palkovits M. [(3)H]-girisopam, a novel selective benzodiazepine for the 2, 3-benzodiazepine binding site. Brain Research. Brain Research Protocols. 1999 Jul;4(2):230-5.